Member Info for neilin62

Excellent interview.
Lots happening and at a fair old pace i would say.
Neil

Yet more good news. Things are certainly happening.
Plenty more to come in my opinion.
Neil

CAW
Interesting your theory on GS.
I posted previously about the shenanigans that took place with PMO.
GS were also involved in a lot of CFD activity there.
Neil

Not sure if anyone has seen it, but Directors Talk has an exclusive interview with Allan Syms on 23rd June. Transcript is also posted in full today.
So he has been busy.
Neil

LB
Many thanks for taking time to post. Appreciated, and keep up the outstanding work on the other one.
Widglide
Someone (ii's) did invest £2.2million here, so they must have believed in it. From what i can see, they have not sold out either.
You can't say they have done nothing regarding media or networking. They clearly have, hence the CRO's, and "We are also investigating additional global strategic alliances",
They are keeping us informed too. Lets be honest we have had more communications in 5 weeks than we had in 2 years previously!
re the comment on not answering why shareholders were shafted, i,m sorry, but i don't agree.
Allan quite clearly spelled out the reasons at 34:30 of the webinar presentation.
Neil

Hi Jace86
The other share is EUA which i have previously given people here a heads up on.
If you ever want to see how blatant the market is manipulating the share price for their own end, then you should look back at it. Fabulous news on all fronts, yet the share price is shown as down every day. Shows buys as sells, and disguising them by the UT, spread, etc.
Note how quick we jumped back up from being over 6% down half an hour ago.
Neil

Not news to rally the troops. This is news that has to be announced to the market.
Excellent news too in my opinion. I refer to my post yesterday saying that more news will come, and here we are.
The share price yesterday should have given a pointer. It was clearly being played.
There is a poster on here ( i won't name in case he does not wish to comment) that has done sterling work on the market manipulation of a certain other share and understands what is going on re the share price.
Neil

Widglide,
I assume you are intimating myself with the comment:
"feeding info to certain share holders who managed to convince everyone this the right deal and now look ...."
Firstly, nobody has been feeding me information. I ask questions, just like you are able to, and i get answers.
Secondly, i haven't convinced anyone this is the right deal. I have repeatedly said that all my posts are in my opinion. You should make your own mind up with your investments.
That said, it is still my opinion that this will be good. Just not in the time frame you were clearly wanting. The prospectus clearly spells out a timetable of events. You say that "they are slow at making it happen" This is bio technology. Nothing happens in weeks. I said that i expected to see the BOD signing up some licensing deals etc fairly soon after listing. We are only what, 5 weeks into listing and they have notified an MOU with some pretty decent numbers., so things are starting to happen. There will be more to come.
As for "rejecting the deal and making a better one" i think i can safely guarantee that that would never have happened. We only had a small amount of cash left, and the cost of an aborted RTO, (don't forget that capital was "pre" raised from investors, so they would not be happy) would have closed us up for good. The relisting costs i think were in the region of £half a million. There is absolutely no way we could start again.
Other companies won't have the same product faster than us.
For a start, the technology is patented. For another, we are far in advance of the technology, with Dr Coverley having presided over this for the time she has.
I was reading an article last night, and it may surprise you to know that it was an article in Peru, that are aware of our company and the technology we have developed.
Yes the share price is a real s*it at the minute, and to be fair, i am hugely down at the minute. But i believe that in time this will be a great company, if everything comes to fruition.
However, do not rely on my opinion.
Neil

Hi Countingcards
Yes, that's correct. I was using the numbers from the prospectus, which includes the warrants, as they are included in the 4.42% stated holding. Without the warrants, this would bring him back to 1.55% as you say.
The issue i have is that despite a request to clarify the holding position, and whether the warrants were taken up, the BOD have not given any clarity on it. However, as i posted some time back, and as you correctly say, there should have been a TR1, which would have cleared it up conclusively.
Not that it matters in the grand scheme of things, but it just throws the numbers out a bit when trying to work out who is increasing/decreasing holdings.
Neil

That's interesting.
According to the register of significant shareholders updated on 7th June , there are a number of changes to holdings declared. Antos Glogowski, our largest individual investor, does not even appear! previously holding 4.42% Did he sell? Where is the TR1? I have raised a query on this.
Yorkshire Cancer research - no change
Finance Yorkshire Seedcorn Fund - no change
Hargreaves Lansdown - below 3% as i posted previously, now not showing.
Dr Dawn Coverley - no change
University of Sheffield - no change
University of Leeds - no change
University of York - no change
Rose Noble ltd - previously holding 5.82%, now not listed, so at least below 3% if not out completely. Where is the TR1?
Bank of New York Nominees - new holder with 6.92%
Roy Nominees - new holder with 6%
Jim Nominees - new holder with 18.38%

The 6% drop today is totally disconnected from the share price. A few thousand quid in trades does not equate to wiping almost £1/2 million of the MCAP.
However, i believe this was more affected by the late published trade tonight from yesterday. An apparent sell of 530,838 shares yesterday. That's what subdued today's good news in my opinion.
Wideglide/JohnnyFunerals, - currently sitting on a bigger loss, but you know where my opinion lies. Just to be clear to all though - only my own opinion.
Neil

Don't know if anyone else picked up on it, but there are a couple of lines in that RNS that are of real interest;
".............already licenced to SGS by a large pharma company, which seeks to address unmet clinical needs in autoimmune disease". A large pharma company.remember the ones i mentioned previously?

"clinical samples, reagents and patient and technical information and, in addition, will provide regulatory and technical advice on securing the required regulatory approvals for the companion diagnostic platform. " Access to reagents, and someone that knows about the regualtory processes already.

All starting to come together.
Neil

Looks like we have started our journey.
This isn't even the focus of our cancer detection route, but a further revenue stream available to us.
Neil

Been researching some more.....
Now before we all get too excited, i,m not saying this will happen in a month or a year or even whenever.
It is just to show you the possible opportunities we could be in.
The world of Bio-Pharma is currently going on an absolutely mind bending mergers and acquisitions phase with the emphasis on oncology.
In the last few month or so alone, these are some of the deals having been completed.
1. Argen licensed their antibody for blood cancers to Johnson & Johnson for $300million upfront payment, with a further $200million equity investment. Potential milestone payments of $1.3 BILLION would bring the investment total to $1.8 BILLION! This is a fascinating one, as their clinical trials data is considered "relatively poor compared with others"
2. Merck acquired Velos Bio in November for the sum of $2.75 BILION in cash!
3. Boehringer acquired NBE Therapeutics for 1.18 BILLION euros
4. By far the next largest is Gilead. Last year they started on a spending spree by acquiring the oncology company "Forty Seven" for a consideration of $4.9 BILLION. Not content with that, they then went on to buy out Imunomedics with a price tag of $21 BILLION
5. In December 2020, AstraZenica, who have been focusing on cancer, stunned the market when they added to their portfolio by acquiring Alexion, with an eye watering $39 BILLION deal !!!!

Today, GlaxoSmithKline announced they signed a deal with iTeos Therapeutics for $625 MILLION upfront payment to develop and commercialize a cancer treatment.
The common thread with all of these M&A's is the emphasis on cancer detection/treatment.
Don't get hung up on the share price today/tomorrow/next week. Look at the potential where this COULD get to.
Neil

RNS no2 today.
Spreadex taken out a 8,314,773 CFD/Spreadbet
Nei

PS Tra1
I get your point about the insurance companies, but there is something here that i think most people have missed.
Our kit will be of huge interest to Life insurance/Critical illness cover/Private health insurers.
Imagine at the minute someone renewing their annual policy and disclosing that they are under investigation for cancer. At the minute, the policy would have to pay for any investigative procedures (CT, tissue biopsy etc) This immediately puts them at a disadvantage financially, the policy holder/patient is understandably fearful, and in most cases, it was all a false positive result. So the poor patient has had to suffer all that for nothing.
Now we come along with our test kit, just draw a little blood, no operation, no chemotherapy, no drugs, no (or at least minimal) patient anxiety. Patient knows one way or the other, but at a very early stage, so even if the worst is true, and they do have cancer, they are far more likely to have a positive response to treatment. Insurers have spent very little. Everyone is a winner.
Neil

Definately not too late.
As Tra1 stated, they are 2 entirely different things.
We are looking at EARLY ( as in MUCH earlier than the others out there) detection at nuclear cell stage, not at 2nd stage or later.
As you mentioned Grail, there are a few things worthy of note.
1. Their Galleri product is being sold in US but has NOT been given approval by FDA. It is being sold under a Clia waiver agreement, but only as a screen, and is aimed at over 50'S who have already been identified as being an elevated risk profile. Our product is cancer type specific, so it can detect exactly which cancer, (not just oh you have cancer) Not only that, but as it is so specific, it can be used to monitor the effects of the drugs prescribed and which ones work best for the best outcome of the patient.
2. They are selling it at a reduced rate to the rest of the market at a price tag of $949.00
The other 2 manufacturers that have an "early" detection kit, are selling those at $5,800.00, and $7,000.00 respectively.
I think our BOD said that our kit could be in the region of £200.00?
Also, with the Galleri product, would you be happy if your doctor told you that he /she could only say that you have a 50/50 chance of cancer if their result gave a positive? I wouldn't.
(46% according to their own figures)
I also note that the research has only been validated by Grail themselves.
Today it has been announced that the takeover planned by Illumina has been delayed due to the FTC filing a complaint authorizing a Federal Court lawsuit to block the $8billion acquisition.
Nice little rise today for us, and RNS for the accounts and AGM notice
Neil

Yes, fined $1.13million, but later reduced for "co-operation!)
They were shorting it between 2017, and 2019, and failed to notify the watchdog 155 times
Neil

CTC1988
It is a distinct possibility yes.
Trouble is we will never really know for sure. You only have to go back a short period and look at PMO and the way they were being shorted without the market knowing ( i believe at one point that ARC was shorting to the tume of 17%+ or £132million without notifying the watchdog)
Either way, there is clear evidence in my eyes that the share price is being manipulated, as described by David.
Best regards
Neil

The trade at 10:31:56 for 85,000 shares at 22.22p IS NOT A SELL! It is my BUY.
For those who are slightly worried about the direction this company is going i would urge you to look up articles posted by DAVID STONE who describes EXACTLY what is going on here.
Type in Why are my stocks red, and there are a number of articles.
Read up on
1. WHY YOUR STOCK IS ALWAYS RED 18th FEB
2. 10 SIGNS YOUR STOCK IS BEING MANIPULATED 11th Feb
3. 10 SIGNS OF AN UPCOMING SHORT SQUEEZE 25th May
Best regards
Neil

Been watching the discussions on the interpretations of the date on which we will get notice.
Under section 1147 of the Act the following would apply:
NOTICE OF AGM POSTED ....... Friday 4th June
This day is not considered part of the "clear days" required.
NOTICE DEEMED AS DELIVERED.......Tuesday 8th June (48 Clear hours)
21 DAYS CLEAR NOTICE PERIOD..........Tuesday 29th June
EARLIEST DATE OF MEETING......Wednesday 30th June.
Therefore, in order to have the AGM on 30th June, we must receive notice FRIDAY 4TH JUNE.
Best regards
Neil